Transcat, Inc. (NASDAQ:TRNS) Shares Purchased by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC increased its stake in shares of Transcat, Inc. (NASDAQ:TRNSFree Report) by 40.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,685 shares of the scientific and technical instruments company’s stock after purchasing an additional 10,238 shares during the period. Rice Hall James & Associates LLC owned 0.39% of Transcat worth $3,773,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of TRNS. nVerses Capital LLC acquired a new position in shares of Transcat during the 3rd quarter worth approximately $60,000. SG Americas Securities LLC acquired a new position in shares of Transcat during the 4th quarter worth approximately $182,000. US Bancorp DE raised its position in shares of Transcat by 15.6% during the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock worth $187,000 after purchasing an additional 209 shares during the last quarter. Captrust Financial Advisors acquired a new position in shares of Transcat during the 3rd quarter worth approximately $201,000. Finally, Walleye Capital LLC purchased a new stake in Transcat in the 3rd quarter worth approximately $216,000. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Down 2.9 %

Shares of NASDAQ TRNS opened at $82.41 on Wednesday. Transcat, Inc. has a 52-week low of $73.37 and a 52-week high of $147.12. The firm has a fifty day moving average of $97.20 and a 200-day moving average of $109.58. The stock has a market capitalization of $767.24 million, a PE ratio of 44.55 and a beta of 0.67. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNSGet Free Report) last announced its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the previous year, the firm posted $0.56 earnings per share. On average, analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have commented on TRNS shares. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Northland Securities reaffirmed a “market perform” rating and issued a $85.00 target price (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. HC Wainwright lowered their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Finally, Craig Hallum lifted their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Transcat has a consensus rating of “Hold” and an average target price of $111.50.

Read Our Latest Stock Report on TRNS

Insider Activity at Transcat

In other Transcat news, Director Craig D. Cairns bought 1,200 shares of Transcat stock in a transaction that occurred on Friday, January 31st. The shares were acquired at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the acquisition, the director now owns 1,910 shares of the company’s stock, valued at $147,108.20. The trade was a 169.01 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 2.30% of the company’s stock.

About Transcat

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.